Devyser and Thermo Fisher Scientific collaborate to promote laboratory services to advance pharmaceutical research
Devyser and Thermo Fisher Scientific have entered into a collaboration agreement to promote...
We help laboratories focus on what matters most to patients – correct and fast diagnosis every time. Our genetic test kits with integrated software set new standards in DNA diagnostic testing.
Post-transplantation monitoring
Screening for early detection of graft rejection and minimal residual disease in bone marrow and stem cell transplant patients. Learn more
Hematology
Tests to evaluate multiple blood conditions and guide personalized treatment and family planning. Learn more
Cardiovascular diseases
Fast diagnosis and cascade screening for monogenic and polygenic familial hypercholesterolemia. Learn more
“Early treatment made possible by more sensitive diagnostic methods is expected to improve patient survival and significantly reduce the costs for management of transplant patients.”
Dan Hauzenberger, MD., Ph.D., Karolinska University Hospital, Stockholm, Sweden
News | September 06, 2023
Devyser and Thermo Fisher Scientific expand the collaboration for post-transplant NGS products by adding BrazilNews | July 17, 2023
Devyser’s NGS products for monitoring of kidney and stem cell transplant patients receive IVDR approvalsNews | June 29, 2023
Devyser launches two new genetic testing solutions for hereditary cancerDevyser and Thermo Fisher Scientific have entered into a collaboration agreement to promote...
Read more
Devyser LynchFAP is the latest addition to Devyser’s expanding hereditary cancer screening...
Read more
Devyser and Thermo Fisher Scientific have agreed to expand commercial collaboration by including...
Read more
Bioiatriki is a leading medical laboratory in Greece, providing a range of prenatal genetic testing...
Read more